Symbol Name ID |
Btg2
BTG anti-proliferation factor 2 MGI:108384 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J |
enlarged uterus | J:211773 |
hyperactivity | J:211773 | |
increased fasting circulating glucose level | J:211773 | |
increased mean corpuscular hemoglobin | J:211773 | |
increased mean corpuscular volume | J:211773 | |
Btg2tm1Spo/Btg2+ involves: 129S4/SvJae * C57BL/6 |
vertebral transformation | J:95124 |
Btg2tm1Spo/Btg2tm1Spo involves: 129S4/SvJae * C57BL/6 |
cervical vertebral transformation | J:95124 |
thoracic vertebral transformation | J:95124 | |
vertebral transformation | J:95124 | |
Btg2tm1Wbh/Btg2tm1Wbh involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
normal nervous system phenotype | J:88653 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|